Login
Medtronic NYSE: MDT
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals
| Name | Medtronic |
| Ticker | MDT |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Specialized Medical Devices |
| Price | 107.81 |
| 52W Low/High | 72.92 / 121.30 |
| Market cap | 145 B |
| 1Y Total Return |
0.01%
Average |
| 1Y Volatility |
39.13%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals
Details
| Ticker | MDT |
| Name | Medtronic |
| ISIN | IE00BTN1Y115 |
| CUSIP | G5960L103 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Specialized Medical Devices |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) |
|
Share as of 9/17/20
| Close Price | 107.81 |
| 52W Low/High | 72.92 / 121.30 |
| Market cap | 145 B |
| 1Y Total Return |
0.01%
Average |
| 1Y Volatility |
39.13%
Low Risk |
| Beta | 0.69 |
| PE (trailing) |
33.07
Above Average |
| 12M Dividends | 2.2 |
| Last Dividend Date | 6/25/20 |
| Dividend Yield | 2.04% |
Fin. Strength
| Net Profit Margin | 15.8% |
| Cash from Op. / Cur. Liabilities | 0.46 |
| Diluted Earnings / Share | 3.26 |
| ROE | 8.8% |
| ROIC | 6.5% |
| Price / Revenue | 5.2 |
| Price / Book | 2.9 |
| Price / CF | 24.2 |
| Current Ratio | 1.9 |
| Cur.Liabilities / Tot.Liabilities | 0.3 |
| Financial Leverage | 0.57 |
| in Mils USD |
rolling-year up to June
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
27,927
|
30,666
|
29,947
|
29,934
|
28,725
|
23,262
|
|
| Gross Profit |
18,364
|
21,349
|
21,028
|
20,549
|
19,778
|
15,602
|
|
| R&D |
2,365
|
2,332
|
2,292
|
2,186
|
2,222
|
1,833
|
|
| EBITDA |
6,983
|
9,425
|
9,436
|
8,837
|
8,183
|
5,601
|
|
| Operating Income |
3,979
|
6,517
|
6,494
|
5,598
|
5,397
|
3,809
|
|
| Net Income exc. Extra |
4,412
|
4,420
|
3,163
|
4,115
|
3,647
|
2,624
|
|
| per Share | |||||||
| Diluted avg Shares |
1,350
|
1,352
|
1,365
|
1,376
|
1,407
|
1,436
|
|
| EPS exc. Extra |
3.26
|
3.27
|
2.31
|
2.97
|
2.57
|
2.11
|
|
| Dividend |
2.20
|
2.04
|
1.88
|
1.75
|
1.57
|
1.30
|
|
| Div. Yield (an.) |
2.28%
|
1.99%
|
2.12%
|
2.08%
|
1.79%
|
1.86%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
93,906
|
91,268
|
89,721
|
100,250
|
98,601
|
104,626
|
|
| Cash, Eq & Invt ShortTerm |
13,012
|
10,683
|
11,004
|
13,088
|
12,810
|
17,982
|
|
| Total Current Assets |
24,509
|
22,705
|
22,460
|
24,779
|
23,498
|
29,147
|
|
| Total Non-Current Assets |
69,397
|
68,563
|
67,261
|
75,471
|
75,103
|
75,479
|
|
| Intangibles |
59,384
|
60,316
|
60,225
|
62,202
|
67,746
|
68,356
|
|
| Total Liabilities |
43,463
|
40,771
|
39,392
|
49,463
|
47,709
|
51,817
|
|
| Total Current Liabilities |
13,086
|
8,518
|
9,112
|
15,148
|
7,896
|
7,660
|
|
| Long Term Debt |
30,377
|
32,253
|
30,280
|
34,315
|
39,813
|
44,157
|
|
| Shareholder equity |
50,296
|
50,363
|
50,224
|
50,672
|
50,824
|
52,809
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
6,002
|
6,815
|
5,649
|
6,067
|
5,952
|
5,408
|
|
| Depreciation |
2,675
|
2,650
|
2,674
|
2,816
|
2,856
|
1,792
|
|
| Cash from Investing |
-2,644
|
-1,968
|
6,418
|
-1,204
|
2,947
|
-18,038
|
|
| Capex |
1,246
|
1,144
|
1,081
|
1,202
|
1,152
|
686
|
|
| Cash from Financing |
-1,965
|
-4,132
|
-12,386
|
-3,264
|
-8,959
|
14,560
|
|
| Stock Issued |
-515
|
-1,634
|
-1,052
|
-2,657
|
-3,236
|
-1,012
|
|
| Debt (LT) Issued |
1,583
|
270
|
-8,694
|
1,820
|
-3,608
|
17,239
|
|
| Free Cash Flow |
11,910
|
6,421
|
-1,220
|
13,292
|
4,278
|
2,486
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
15.8%
|
14.4%
|
10.6%
|
13.7%
|
12.7%
|
11.3%
|
|
| NCFO / Op.Income |
150.8%
|
104.6%
|
87.0%
|
108.4%
|
110.3%
|
142.0%
|
|
| Current Ratio |
1.9
|
2.7
|
2.5
|
1.6
|
3.0
|
3.8
|
|
| Financial Leverage D/E |
0.57
|
0.52
|
0.50
|
0.67
|
0.63
|
0.67
|
|
| Return on Capital Avg |
6.5%
|
8.0%
|
4.2%
|
6.0%
|
4.6%
|
4.9%
|
|
| Return on Shareholder Equity |
8.8%
|
8.8%
|
6.3%
|
8.1%
|
7.0%
|
7.3%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available